publity AG

  • WKN: 697250
  • ISIN: DE0006972508
  • Land: Deutschland

Nachricht vom 06.09.2019 | 12:08

publity AG: Change in the Supervisory Board of publity AG

DGAP-News: publity AG / Key word(s): Personnel/Real Estate

06.09.2019 / 12:08
The issuer is solely responsible for the content of this announcement.


Press Release

Change in the Supervisory Board of publity AG

Frankfurt 06 September 2019 - Prof. Dr. med. Holger Till (57) has been newly appointed to the Supervisory Board of publity AG (Scale, ISIN DE0006972508). Prof. Till has been active internationally in various management positions for more than two decades and has experience both in committees of listed companies and in the real estate sector in marketing and sales of larger real estate packages. Prof. Till is appointed by the court after the previous Deputy Chairman of the Supervisory Board, Norbert Kistermann, resigned for personal reasons. The Supervisory Board and Executive Board would like to thank Mr. Kistermann for his committed and successful work on the Supervisory Board of publity AG.

In the future, the Supervisory Board will consist of Hans-Jürgen Klumpp (Chairman), Prof. Dr. med. Holger Till (Deputy Chairman) and Frank Vennemann.

Press Contact:

Financial Press and Investor Relations:edicto GmbHAxel Mühlhaus/ Peggy KropmannsPhone: +49 69 905505-52
eMail: publity@edicto.de


About publity

publity AG ("publity") is an asset manager and investor specialised in office real estate in Germany. The company covers the core of the value chain from the acquisition to the development and the sale of real estate. With over 1,100 transactions in the past seven years, publity is one of the most active players in the real estate market. Currently, the company manages a portfolio with a value of over five billion euros. publity is characterized by a sustainable network in the real estate industry and in the Work-Out departments of financial institutions. With very good access to investment funds, publity handles transactions rapidly with a highly efficient process and proven partners. On a case-by-case basis, publity participates as co-investor in joint venture transactions to a limited extent. The shares of publity AG (ISIN DE0006972508) are traded on the Scale segment of Deutsche Börse.



06.09.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

Anleihe im Fokus

Deutsche Rohstoff
"Anleihe - Jetzt zeichnen!"

- Emissionsvolumen: bis zu 100 Mio. EUR
- Zeichnungsfrist: 11.11. bis 04.12.2019
- ISIN: DE000A2YN3Q8 / WKN: A2YN3Q
- Börsenesegment: Börse Frankfurt, Open Market (Quotation Board)
- Stückelung / Emissionspreis: 1.000 EUR/ 100%
- Zinssatz (Kupon): 5,25 %
- Laufzeit: 5 Jahre
- Fälligkeit: 5 Jahre / 6.12.2024 (vorbehaltliche vorzeitige Rückzahlung gemäß Anleihebedingungen)
- Zinszahlung: Angebot an Inhaber der 5,625 % Schuldverschreibung 2016/2021 (WKN A2AA05, ISIN DE000A2AA055) diese in die neue Anleihe zu tauschen
- Umtauschfrist: 11.11.2019 – 29.11.2019 (18.00 Uhr)

GBC-Fokusbox

Expedeon AG mit attraktiver Produktpipeline

Durch die konsequente Fortsetzung der „Grow, Buy & Build“-Strategie hat die im Bereich der Entwicklung und Vermarktung von DNA-Technologien, Proteomik- und Antikörper-Konjugations-Anwendungen tätige Expedeon AG das Umsatzniveau angehoben und auf operativer Ergebnisebene zugleich den Break-Even nachhaltig überschritten. Für die kommenden Perioden ist der Ausbau der Umsatzerlöse mit den bestehenden Produkten geplant. Darüber hinaus verfügt die Expedeon AG über eine attraktive Produktpipeline mit hohem Umsatzpotenzial. Unser Kursziel liegt bei 3,20 € je Aktie. Das Rating lautet KAUFEN.

News im Fokus

Henkel AG & Co. KGaA: Henkel bestätigt Ausblick für das Geschäftsjahr 2019

14. November 2019, 07:30

Aktueller Webcast

EQS Group AG

Conference Call zu den Neunmonatszahlen 2019

15. November 2019

Aktuelle Research-Studie

Uzin Utz AG

Original-Research: Uzin Utz AG (von Montega AG): Kaufen

15. November 2019